September 19th 2025
CDC panel shifts vaccine policy by discouraging combined MMRV shot for young children due to increased febrile seizure risk.
FDA Grants Approval to Celltrion for Expanded Indication of Actemra Biosimilar to Treat CRS
Published: August 8th 2025 | Updated: August 8th 2025The company’s expanded label for Avtozma (tocilizumab-anoh) now includes the treatment of cytokine release syndrome, aligning the therapy with all indications for which Actemra is approved in the US.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
Pelletization: Revolutionizing Drug Formulation and Delivery
July 15th 2024Pelletization, a popular oral drug delivery method in pharmaceuticals and nutraceuticals, offers numerous benefits. This article delves into the critical parameters for formulation development and technological consideration in pelletization, elucidating its significance in advancing pharmaceutical solutions.